Dr Anil Tukarampant Bangale, MD | |
5201 River Oaks Blvd, River Oaks, TX 76114-2923 | |
(817) 626-5424 | |
(817) 626-4354 |
Full Name | Dr Anil Tukarampant Bangale |
---|---|
Gender | Male |
Speciality | Family Medicine - Sports Medicine |
Location | 5201 River Oaks Blvd, River Oaks, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124071154 | NPI | - | NPPES |
111743401 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207QS0010X | Family Medicine - Sports Medicine | E7370 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Anil Tukarampant Bangale, MD 5201 River Oaks Blvd, River Oaks, TX 76114-2923 Ph: (817) 626-5424 | Dr Anil Tukarampant Bangale, MD 5201 River Oaks Blvd, River Oaks, TX 76114-2923 Ph: (817) 626-5424 |
News Archive
Kaneka Corporation on 19/09/2012, announces the launch of KANEKA KanCapA, a new Protein A Chromatography Resin for the purification of therapeutic antibodies.
The Center for Disease Control reports that adults with disabilities are three times more likely to have heart disease, diabetes, cancer or other chronic diseases than adults without disabilities. Taking a pro-active approach to keep their clients as healthy as possible, Victory Living Programs (VLP) has partnered with Special Olympics Florida to bring the Healthy Community program to VLP.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today its participation in a $2.4 million research grant awarded to the University of Pennsylvania under the "American Recovery and Reinvestment Act of 2009". The new grant will fund research over two years in the laboratories of Daniel Rader, M.D. of the University of Pennsylvania School of Medicine, Sekar Kathiresan, M.D. of Massachusetts General Hospital (MGH) and Harvard Medical School, and Alnylam.
ReCor Medical announced today that it has commenced a 50-patient, post-market study across multiple sites in Europe with its CE-marked next-generation PARADISE system, a minimally invasive 6Fr Over-The-Wire (OTW) ultrasound device for treating resistant high blood pressure.
For the first time, a surgical robot has been used to perform minimally invasive reconstructive surgery on five children whose bladder was dysfunctional because they were born with spina bifida [incomplete formation of the spine or spinal cord].
› Verified 7 days ago